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procedure on our patients for purely scientific reasons outside the
context of indicated biopsies .
All rejection episodes were International Society in Heart and
Lung Transplantation grade 3A and greater, and baseline was
considered grade 0 to 1 . Blood samples were not taken during
surgery and there was no evidence of active viral infection at the
time of cytokine measurement . Active infection was an exclusion
criterion for inclusion of data into the study .
We believe that our study does not prejudice the further devel-
opment of monoclonal antibodies, mainly because Jennison et al .
misunderstand the aim of our study . This was an observational
study to examine which cytokines are being released and only
secondarily to correlate these cytokines with rejection . The study
does not have the power to address the latter question, We should
have stated that there is no obvious relation between a particular
cytokine and rejection ; this does not imply that a relation does not
exist . In fact, our Figure 7 suggests that a relation may well exist .
We believe that documenting that a number of cytokines other than
IL-2 receptor (Ref . 3 to 8 of Dennison et al .) are being release(] from
the cardiac allograft (and not irom some unknown peripheral site)
provides exciting new potential therapeutic options .
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Pulmonary Embolism After CardWc Surgery
I was impressed by the unusually high incidence of pulmonary
embolism after cardiac operations in the report by Josa and associ-
ates (1) . Their retrospective data led logically to the conclusion that
the incidence of pulmonary embolism in the patients undergoing
coronary artery bypass grafting (3 .9%) is higher than that (3%)
reported by Kakkar et al . (2) in a prospective study of patients
undergoing general surgical operations . However, I feel uncomfort-
able with their conclusion because we recently reported different
results (3) on the same issue .
In our report (3), we reviewed the clinical records of 4,393
patients who underwent cardiac surgery requiring cardiopulmonary
bypass at a large university hospital between January 1984 and
December 1988 . Of these, only 13 patients developed venous
thromboembolism postoperatively . There were eight cases of deep
vein thrombosis and five of pulmonary embolism . Three of the
patients with pulmonary embolism underwent coronary artery by-
pass grafting and two had aortic valve replacement . Pulmonary
embolism accounted for the death of one patient . Follow-up data
were available in all patients and averaged 38 ± 5 .6 months (range 2
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Figure 1 . Survival rate and incidence of deep vein thrombosis
(DVT) and pulmonary embolism (PE) in 4,393 patients who under-
went cardiac surgery requiring cardiopulmonary hospital at a large
university hospital between January 1984 and December 1988 .
Reprinted, with permission, from Canver and Fiedler (3) .
to 72) . Actuarial survival at 5 years was 92% after a cardiac
operation (Fig . 1) .
Our observations agree with their proposed risk factors of
prolonged immobility, obesity and previous deep vein thrombosis .
However, the incidence of venous thromboembolism after open
heart surgery was 0 .3% in our series (3) . The increasing use of
intravenous and oral anticoagulant agents before open heart surgery
and the routine use of platelet suppressant therapy may offer
possible explanations for the observed low occurrence of postoper-
ative pulmonary embolism in this subset of patients . Based on our
experience, it appears that the 3 .9% incidence of pulmonary embo-
lism among cardiac surgical patients is extremely high .
In many cases of pulmonary embolism occurring after general
surgical operations, deep vein thrombosis is the most common
source for dislodgment of a clot in the pulmonary circuit . It is
unclear why the incidence of deep vein thrombosis is very low iii
pulmonary embolism cases in the series of Josa and associates (I) .
This discrepancy requires explanation .
Limitations of retrospective studies on this complex issue em-
phasize the need for a randomized prospective study to investigate
the true incidence of venous thromboembolic complications after
cardiac surgery .
CHARLES C. CANVER, MD, FACC
Division of Cardiothoracic Surgery
University of
Wisconsin-Madison Medical School
H41352, Clinical Science Center
600 Highland Avenue
Madison, Wisconsin 53792
References
I . Josa M, Siouffi SY . Silverman AB . Barsamian EM
. Khuri SF . Sharma GvRK.
Pulmonary embolism after cardiac surgery . I Am Coll Cardiol 1"3
;21 :990-6 .
2 . Kakkar VV
. Howie CT . Flanc C . Clarke MB . Natural history of postoperative deep
vein thrombosis . Lancet 1%9 ;2
:230-2 .
3 . Canver CC . Fiedler RC
. Venous thromboembolic complications after open hear ,
surgery . Vase Sorg 1992 :26 :21 13- 7 .
Reply
Canver's letter raises two important issues : the incidence of deep
vein thrombosis and pulmonary embolism after cardiac surgery .
With respect to the first, it was not the aim of our study to determine
the incidence of deep vein thrombosis in patients undergoing cardiac
surgery . Although deep vein thrombosis precedes pulmonary em-
bolism, it is usually asymptomatic and can be detected only by
